uniQure

uniqure.com

uniQure is a leader in gene therapy, delivering innovative cures through its proprietary AAV-based technology platform. The company has achieved significant milestones, including the first approved gene therapy for hemophilia B and a clinical program for Huntington's disease. With a focus on serious unmet medical needs, uniQure is advancing a growing pipeline of gene therapies, leveraging its commercial-grade manufacturing capabilities and a commitment to quality and patient-centric care. Their mission is to transform lives through groundbreaking gene therapies, positioning them as a key player in the genomic medicine landscape.